A Study of Plasmatic Concentrations of Endothelin-1 (ET1), Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP) in Acute Ischemic Stroke.
Completed
Phase N/A Results N/ASummary of Purpose
A study of plasmatic concentrations of endothelin-1 (ET1), atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) in acute ischemic stroke.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 28 November 2007.
1 Nov 2001 | 13 Sep 2005 | Unavailable | 1 Mar 2004 | 1 Nov 2007 | Unavailable |
Start Date | First Received | 1st Completion | Completion | Verification | Results |
---|
Trial Design
- Perspective: Prospective
Contacts
Not available
View Trial Locations
Recruitment
- Enrollment: 14
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 1 location, 1 country
Principal Investigator
- Andoni Echanz-Laguna, MD
Hopitaux Universitaires de Strasbourg